Deep Bayesian networks for uncertainty estimation and adversarial resistance of white matter hyperintensity segmentation

White matter hyperintensities (WMHs) are frequently observed on structural neuroimaging of elderly populations and are associated with cognitive decline and increased risk of dementia. Many existing WMH segmentation algorithms produce suboptimal results in populations with vascular lesions or brain...

Full description

Saved in:
Bibliographic Details
Published in:Human brain mapping Vol. 43; no. 7; pp. 2089 - 2108
Main Authors: Mojiri Forooshani, Parisa, Biparva, Mahdi, Ntiri, Emmanuel E., Ramirez, Joel, Boone, Lyndon, Holmes, Melissa F., Adamo, Sabrina, Gao, Fuqiang, Ozzoude, Miracle, Scott, Christopher J. M., Dowlatshahi, Dar, Lawrence‐Dewar, Jane M., Kwan, Donna, Lang, Anthony E., Marcotte, Karine, Leonard, Carol, Rochon, Elizabeth, Heyn, Chris, Bartha, Robert, Strother, Stephen, Tardif, Jean‐Claude, Symons, Sean, Masellis, Mario, Swartz, Richard H., Moody, Alan, Black, Sandra E., Goubran, Maged
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-05-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:White matter hyperintensities (WMHs) are frequently observed on structural neuroimaging of elderly populations and are associated with cognitive decline and increased risk of dementia. Many existing WMH segmentation algorithms produce suboptimal results in populations with vascular lesions or brain atrophy, or require parameter tuning and are computationally expensive. Additionally, most algorithms do not generate a confidence estimate of segmentation quality, limiting their interpretation. MRI‐based segmentation methods are often sensitive to acquisition protocols, scanners, noise‐level, and image contrast, failing to generalize to other populations and out‐of‐distribution datasets. Given these concerns, we propose a novel Bayesian 3D convolutional neural network with a U‐Net architecture that automatically segments WMH, provides uncertainty estimates of the segmentation output for quality control, and is robust to changes in acquisition protocols. We also provide a second model to differentiate deep and periventricular WMH. Four hundred thirty‐two subjects were recruited to train the CNNs from four multisite imaging studies. A separate test set of 158 subjects was used for evaluation, including an unseen multisite study. We compared our model to two established state‐of‐the‐art techniques (BIANCA and DeepMedic), highlighting its accuracy and efficiency. Our Bayesian 3D U‐Net achieved the highest Dice similarity coefficient of 0.89 ± 0.08 and the lowest modified Hausdorff distance of 2.98 ± 4.40 mm. We further validated our models highlighting their robustness on “clinical adversarial cases” simulating data with low signal‐to‐noise ratio, low resolution, and different contrast (stemming from MRI sequences with different parameters). Our pipeline and models are available at: https://hypermapp3r.readthedocs.io. We present a robust and efficient WMH segmentation model, which also generates an uncertainty map for quality control. In addition, we present a second model to classify dWMH and pvWMH using the initial total WMH segmentation. Our segmentation models achieved high accuracy compared to SOTA algorithms on a wide spectrum of WMH burdens, especially mild WMH. Additionally, we used an augmentation scheme to make our model robust to simulated images with SNR, low resolution, and different contrasts.
Bibliography:Funding information
Canadian Institute for Health Research, Grant/Award Number: MOP Grant #13129; Canadian Institutes of Health Research, Grant/Award Numbers: Foundation grant #159910, MOP‐82744; Ontario Brain Institute and the L.C Campbell Foundation; the Medical Imaging Trial Network of Canada (MITNEC), Grant/Award Number: Grant #NCT02330510; Windsor/Essex County ALS Association; University of Ottawa Faculty of Medicine; University Health Network; the Thunder Bay Regional Health Sciences Centre; Sunnybrook Health Sciences Centre Foundation; St. Michael's Hospital Foundation; Queen's University Faculty of Health Sciences; Ottawa Brain and Mind Research Institute; McMaster University Faculty of Health Sciences; London Health Sciences Foundation; Centre for Addiction and Mental Health Foundation
Sandra E. Black and Maged Goubran are co‐senior authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding information Canadian Institute for Health Research, Grant/Award Number: MOP Grant #13129; Canadian Institutes of Health Research, Grant/Award Numbers: Foundation grant #159910, MOP‐82744; Ontario Brain Institute and the L.C Campbell Foundation; the Medical Imaging Trial Network of Canada (MITNEC), Grant/Award Number: Grant #NCT02330510; Windsor/Essex County ALS Association; University of Ottawa Faculty of Medicine; University Health Network; the Thunder Bay Regional Health Sciences Centre; Sunnybrook Health Sciences Centre Foundation; St. Michael's Hospital Foundation; Queen's University Faculty of Health Sciences; Ottawa Brain and Mind Research Institute; McMaster University Faculty of Health Sciences; London Health Sciences Foundation; Centre for Addiction and Mental Health Foundation
ISSN:1065-9471
1097-0193
DOI:10.1002/hbm.25784